Last reviewed · How we verify
NCT06163716: GOIZ_ZAINDU
GOIZ ZAINDU Feasibility Multi Domain Trial to Prevent Dementia.
NA trial testing Multidomain intervention (MD-Int) group in Cognitive Decline in 125 participants. Completed in 1 March 2020.
1 March 2020
Quick facts
| Lead sponsor | Fundacion CITA-alzheimer |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 125 |
| Start date | 1 April 2018 |
| Primary completion | 1 March 2020 |
| Estimated completion | 1 March 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Multidomain intervention (MD-Int) group
Conditions studied
- Cognitive Decline — all drugs for Cognitive Decline →
- Dementia Risk Factors — all drugs for Dementia Risk Factors →
- Prevention — all drugs for Prevention →
- Multidomain Intervention — all drugs for Multidomain Intervention →
Sponsor
Fundacion CITA-alzheimer
Who can join
60 and older, any sex, with Cognitive Decline or Dementia Risk Factors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
GOIZ ZAINDU ("caring early" in Basque) is a pilot study to adapt the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) methodology to the Basque population and evaluate feasibility and adherence to a FINGER-like multidomain intervention program. Additional aims included the assessment of efficacy on cognition and collecting data to design a large efficacy trial.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe.
Tainta M, Ecay-Torres M, de Arriba M, Barandiaran M, et al · · 2024 · cited 19× · PMID 38413990 · DOI 10.1186/s13195-024-01393-z
Verify or expand the search:
- PubMed search for NCT06163716
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognitive Decline
Currently open trials in the same condition.
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT07394504 — Effects of Turning Based Dual Task Training on Balance and Mild Cognitive Impairment in Diabetic Peripheral Neuropathy · NA · recruiting
- NCT07127965 — Exercise Adherence and Cognitive Decline: Phase 2 · NA · recruiting
- NCT07151365 — Plant-based Diets and Healthy Aging · recruiting
- NCT07399418 — TRIAD - Tracking Risk in Integrated Alzheimer's Diagnostics. · recruiting
Other Fundacion CITA-alzheimer trials
Trials by the same sponsor.
- NCT04840030 — Preventing Cognitive Decline: The CITA GO-ON Multi-domain Intervention Study · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06163716 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundacion CITA-alzheimer
- Last refreshed: 11 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06163716.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing